Skip Navigation

Memorial Sloan-Kettering Cancer Center-Adult

1275 York Avenue
Box 552
New York, NY 10065
(877) 836-2268
http://www.mskcc.org/mskcc/html/15467.cfm

Number of Transplants Performed

This center has been performing allogeneic transplants since 1973 and has been an NMDP transplant center since February 1988.

Transplants Reported (From Jan. 2011 to Dec. 2012 as reported by the centers)       Unrelated or Related Donor Auto-
logous

(PBSC or marrow)
Total (by transplant type)
Marrow PBSC Cord
Blood
Unrelated Donor
- Adult
6 141 40 --- 187
Unrelated Donor
- Pediatric
0 0 0 --- 0
Related Donor
- Adult
1 89 0 --- 90
Related Donor
- Pediatric
0 0 0 --- 0
Autologous
- Adult
--- --- --- 170 170
Autologous
- Pediatric
--- --- --- 0 0
Total
(by cell source)
7 230 40 170 447

To find centers that perform cord blood transplants, use the Search Tool on this site.


Patient Survival Information for this Center

Memorial Sloan Kettering Cancer Center - Adults


This center's actual 1-year survival results are above the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2010, 2011 and 2012, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 409 patients.

The actual 1-year survival of these patients is 70.3%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 57.8% and 66.8%.

For help with understanding these statistics, please see Understanding Transplant Outcomes (PDF).


Transplant Results by Patient's Age, Disease Type and Stage

Memorial Sloan-Kettering Cancer Center-Adult - Related

Survival by Patient's Age, Disease Type and Stage after Related Donor Transplantation

This report is based on first allogeneic transplants performed between January 2009 and December 2011 using related donors. It only includes patients with known survival status at 1-year post-transplant. In some cases, patients may have been alive at last reported follow-up that was less than one year. Those patients have not been included in this report. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.


Diagnosis 0-9 Yrs 10-19 Yrs 20-29 Yrs 30-39 Yrs 40-49 Yrs 50-59 Yrs 60+ Yrs Overall
Acute lymphoblastic leukemia in first complete remission -- -- 1/1 1/1 2/2 1/2 2/3 7/9
Acute lymphoblastic leukemia in second complete remission -- -- -- 0/1 3/3 1/1 0/1 4/6
Acute lymphoblastic leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- 1/1 -- 0/1 -- 1/2
Acute myelogenous leukemia in first complete remission -- -- 0/2 1/1 7/9 9/11 8/10 25/33
Acute myelogenous leukemia in second complete remission -- -- -- 1/1 1/3 -- 4/4 6/8
Acute myelogenous leukemia in third or higher complete remission, relapse, or primary induction failure -- -- 1/1 0/1 -- 1/1 0/1 2/4
Chronic lymphocytic leukemia and other chronic leukemia -- -- -- -- 3/3 2/2 2/4 7/9
Chronic myelogenous leukemia in accelerated phase or second chronic phase -- -- -- -- 2/2 -- -- 2/2
Hodgkin lymphoma -- -- 3/3 1/1 1/1 -- -- 5/5
Multiple myeloma / Plasma cell disorder -- -- -- -- 3/3 1/5 1/4 5/12
Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast -- -- -- -- 2/2 1/1 4/5 7/8
Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2)) -- -- -- -- -- -- 1/2 1/2
Myelodysplastic disorders - Other MDS -- -- -- -- 0/1 2/2 1/1 3/4
Myeloproliferative syndromes -- -- -- -- -- -- 1/1 1/1
Non-Hodgkin lymphoma -- -- 2/3 -- 3/5 7/8 2/3 14/19
Other acute leukemia -- -- 1/1 -- 1/1 -- -- 2/2
Severe aplastic anemia -- -- -- -- 2/2 1/2 1/1 4/5
Total -- -- 8/11 5/7 30/37 26/36 27/40 96/131

Memorial Sloan-Kettering Cancer Center-Adult - Unrelated

Survival by Patient's Age, Disease Type and Stage after Unrelated Donor Transplantation

This report is based on first allogeneic transplants performed between January 2009 and December 2011 using unrelated donors. It only includes patients with known survival status at 1-year post-transplant. In some cases, patients may have been alive at last reported follow-up that was less than one year. Those patients have not been included in this report. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.


Diagnosis 0-9 Yrs 10-19 Yrs 20-29 Yrs 30-39 Yrs 40-49 Yrs 50-59 Yrs 60+ Yrs Overall
Acute lymphoblastic leukemia in first complete remission -- -- 1/2 1/1 -- 2/4 2/2 6/9
Acute lymphoblastic leukemia in second complete remission -- -- 3/3 1/1 1/1 -- -- 5/5
Acute lymphoblastic leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- 1/1 2/3 0/1 1/1 4/6
Acute myelogenous leukemia in first complete remission -- 1/1 2/3 7/8 2/3 10/11 9/20 31/46
Acute myelogenous leukemia in second complete remission -- -- 0/1 0/1 1/4 1/2 2/4 4/12
Acute myelogenous leukemia in third or higher complete remission, relapse, or primary induction failure -- -- -- 2/5 1/2 1/5 1/2 5/14
Chronic lymphocytic leukemia and other chronic leukemia -- -- -- -- 2/4 3/5 4/4 9/13
Chronic myelogenous leukemia in first chronic phase -- -- -- 0/1 1/1 1/1 -- 2/3
Chronic myelogenous leukemia in accelerated phase or second chronic phase -- -- -- 1/1 0/1 2/2 -- 3/4
Histiocytic disorders -- -- -- 1/1 -- -- -- 1/1
Hodgkin lymphoma -- -- 1/1 4/4 1/1 1/1 -- 7/7
Multiple myeloma / Plasma cell disorder -- -- -- 2/2 1/4 7/10 3/5 13/21
Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast -- -- -- 3/3 2/3 3/4 1/1 9/11
Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2)) -- -- 1/1 -- 3/4 3/4 6/9 13/18
Myelodysplastic disorders - Other MDS -- -- -- -- -- 4/4 0/2 4/6
Myeloproliferative syndromes -- -- -- 0/1 -- -- 1/1 1/2
Non-Hodgkin lymphoma -- -- 1/2 3/5 5/6 15/20 7/9 31/42
Other acute leukemia -- -- 2/2 -- -- -- 1/1 3/3
Total -- 1/1 11/15 26/35 22/37 53/74 38/61 151/223

Program Description:

Physicians at Memorial Sloan-Kettering Cancer Center (MSKCC) have performed unrelated stem cell transplants since 1973. Many have also held leadership roles in the National Marrow Donor Program (NMDP) network, including chairperson of the Board and chairpersons of NMDP committees. Prior to 2010, the adult and pediatric transplant programs at MSKCC operated as a joint transplant program with combined reporting of data. The two programs are now independent NMDP transplant programs with separate outcomes reporting. The adult program data prior to 2010 can be accessed through the NMDP or by contacting MSKCC. Please see Memorial Sloan-Kettering Cancer Center - Peds for specific information regarding our pediatric BMT program.

Contact Information:

If you have transplant-related questions, please contact Courtney Byam, transplant center coordinator, at (212) 639-7432 or by e-mail at byamc@mskcc.org.

Program Type:

Adult

Attending Physicians:

(Medical Doctors)

Adult -

Juliet Barker, Hugo Castro-Malaspina, David Chung, Parastoo Dahi, Sergio Giralt, Jenna Goldberg, Boglarka Gyurkocza, Alan Hanash, Katharine Hsu, Ann Jakubowski, Robert Jenq, Guenther Koehne, Heather Landau, Matthew Matasar, Craig Moskowitz, Esperanza B. Papadopoulos, Miguel Perales, Doris Ponce, Craig Sauter, Brian Shaffer, Roni Tamari, Marcel van den Brink, James W. Young

Transplants Performed:

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on:

Adult only

Find research trials at this center here:

ClinicalTrials.gov

Estimated Search & Transplant Costs

The costs for a transplant vary greatly from center to center and depend on factors such as health insurance, disease type and disease stage of the patient, as well as center-specific billing policies. Examples of costs in the search and transplant include:

  • The amount and geographic location of donors tested
  • Testing needed to confirm a match
  • Processing and collecting of tissue-typing samples
  • Donor workup testing needed
  • Getting the marrow, PBSC or cord blood unit for transplant

For the best understanding of costs of transplant and follow-up for a specific transplant center, contact the center's Financial Representative.

help Explain Transplant Costs at Different Centers

Resources for financial information

If you have questions about costs and financial services at this transplant center, you can contact the center's financial representative

Financial services at this center could include:

  • Health insurance information
  • Financial assistance
  • Patient-related resources

Additional Information

Further information about this center, including the number and type of transplants performed in each of the last three years, and the support groups offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.

BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.